-
公开(公告)号:US20230035072A1
公开(公告)日:2023-02-02
申请号:US17784579
申请日:2020-12-11
Applicant: Alector LLC
Inventor: Robert PAUL , Michael F. WARD , Hua LONG , Shiao-Ping LU , Omer Rizwan SIDDIQUI , Arnon ROSENTHAL
Abstract: The present disclosure is generally directed to antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics. The present disclosure is further directed to the methods of treating and/or delaying the progression of a disease or injury in an individual by administering such antibodies.